CLIP ; DHLAG ; Gamma chain of class II antigens ; HLA class II histocompatibility antigen gamma chain ; HLA-DR antigens-associated invariant chain ; HLADR-gamma (HLADG) ; Ia antigen-associated invariant chain ; la-gamma ; Major histocompatibility complex class II invariant chain ; MHC HLA-DR gamma chain
Categories
Primary Antibodies
Cellular Localization
Cell Surface, Paranuclear globular
Chromosome Location
5q33.1
Clonality
Monoclonal
Description
It recognizes a protein of ~35kDa, identified as CD74 (Workshop IV). CD74 is a type II transmembrane protein which binds to the peptide binding groove of newly synthesized MHC class II alpha/beta heterodimers and prevents their premature association with endogenous polypeptides. CD74 is expressed primarily by antigen presenting cells, such as B-lymphocytes (from before the pre-B cell stage to before the plasma cell stage), macrophages, and monocytes, and many epithelial cells. Anti-CD74 stains predominantly germinal center lymphocytes and B-cell lymphomas, but rarely T-cell lymphomas. Anti-CD74 has been shown to be useful in differentiating atypical fibroxanthoma (-) from malignant fibrous histiocytoma (+).
Host
Mouse
Immunogen
SU-DHL-4 lymphoma cells
Positive Control
Daudi or Raji Cells. Tonsil or lymph node.
Reactivity
Human, Baboon, Mouse
Recombinant
FALSE
Regulatory
RUO
Swissprot
P044233
Uniprot
436568
Gene Id
972
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
FACS, IF, IHC-F
Description
(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F